ArticleCerebellum (London, England)2026
Novel Imaging Phenotype in Spinal Cerebellar Ataxia Type 8: Symmetrical White Matter Changes without Cerebellar Atrophy.
Article in Cerebellum (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Spinal Cerebellar Ataxia Type 8 (SCA8) is a rare autosomal dominant neurodegenerative disorder characterized by progressive cerebellar dysfunction. It is caused by pathogenic expansions of a CTG/CAG trinucleotide repeat sequence within the ATXN8OS/ATXN8 gene locus on chromosome 13q21. Although cerebellar atrophy is widely recognized as a cardinal neuroimaging feature of SCA8, the phenotypic spectrum remains incompletely characterized. This study identified two cases of SCA8 through genetic analysis. Pedigree information was gathered and analyzed for all available family members. A systematic literature review was conducted to identify all published SCA8 cases with available neuroimaging data. The distinctive clinical and radiological features of SCA8 were analyzed through detailed case characterization integrated with a comprehensive review of existing literature. We report two genetically confirmed SCA8 cases exhibiting a previously undescribed neuroimaging phenotype. Case 1: A 36-year-old woman presented with a one-year history of progressive gait ataxia. Brain MRI revealed confluent, symmetric white matter signal abnormalities without cerebellar atrophy. Repeat expansion analysis detected a pathogenic CTG/CAG expansion of 9/77 in the ATXN8 gene. Case 2: A 64-year-old man (father of case 1) exhibited significant gait abnormalities, cognitive impairment and dysarthria. Brain MRI showed symmetric white matter lesions similar to case 1, with a CTG/CAG repeat length of 17/73. Notably, our systematic review revealed no prior reports of SCA8 presenting with isolated, symmetric white matter abnormalities in the absence of cerebellar atrophy. These findings delineate a novel neuroimaging phenotype of SCA8, characterized by symmetric white matter alterations without cerebellar volume loss. This atypical presentation expands the radiological spectrum of SCA8 and underscores the importance of considering repeat expansion disorders in the differential diagnosis of leukoencephalopathies, even in the absence of classic neurodegenerative imaging signatures.
Indexed as
Identifiers
42105044What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.